What is it about?

a review about the bile acid modified NorUDCA and its potential therapeutic roles in cholestatic diseases as well as in cholangiopathies and metabolism

Featured Image

Why is it important?

it gives a clear overview on a drug which is in final clinical trials and could be a game changer in hepatology

Read the Original

This page is a summary of: Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders, Digestive Diseases, May 2015, Karger Publishers,
DOI: 10.1159/000371904.
You can read the full text:

Read

Contributors

The following have contributed to this page